Nabukenya Sylvia, Okoboi Stephen, Nakate Vivian, Twimukye Adelline, Opio Bruce, Castelnuovo Barbara
Research Department, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
JAMIA Open. 2022 Jul 14;5(3):ooac059. doi: 10.1093/jamiaopen/ooac059. eCollection 2022 Oct.
The aim of this study was to explore researchers' experience of using the regulatory affairs information system (RAIS) in strengthening research compliance to national ethics guidelines through tracking ethics and regulatory approvals for research projects at the Infectious Diseases Institute.
We conducted a cross-sectional study using purposive sampling of 50 participants who were principal investigators (PI) and study coordinators (SC) of active projects between November 2019 and January 2020. Only 36 of them responded to the survey. We also conducted 12 key informant interviews among PI, SC, and research management at the Institute. We used STATA 13 to analyze responses to the survey. The interviews lasted between 20 and 30 min. We used NVivo 10 software to manage the transcripts and generation of themes.
Majority 19 (52.8%) of those who participated in the survey were study coordinators, 19 (52.8%) had participated in more than 5 research studies, 28 (90.3%) had ever received a notification from the RAIS and 26 (92.9%) submitted requests for renewal of their studies approvals to Ethics committees and regulatory bodies 4 weeks prior to expiration dates. The study also examined participants' general understanding of the regulatory requirements and all were aware that RECs and NDA grant approval for a period of 1 year, and 35 (97.2%) that UNCST grants approval for the duration of the study. Three prominent themes; researchers' experiences, benefits, and shortcomings of RAIS were generated from the key informant interviews.
Having experience in research coupled with a novel automated system provides a platform for a better understanding of research regulatory requirements, hence compliance to the national guidelines.
Our case study demonstrates that supporting researchers and research institutions in low resource settings with an automated system in tracking expiration dates for research approvals can facilitate compliance to national ethics guidelines.
本研究旨在探讨研究人员在传染病研究所通过跟踪研究项目的伦理和监管批准情况,利用监管事务信息系统(RAIS)加强研究对国家伦理准则的遵守方面的经验。
我们于2019年11月至2020年1月期间,采用目的抽样法对50名参与者进行了横断面研究,这些参与者是活跃项目的主要研究者(PI)和研究协调员(SC)。其中只有36人回复了调查。我们还对该研究所的PI、SC和研究管理人员进行了12次关键信息访谈。我们使用STATA 13分析调查回复。访谈持续了20至30分钟。我们使用NVivo 10软件管理访谈记录并生成主题。
参与调查的多数人中有19人(52.8%)是研究协调员,19人(52.8%)参与过5项以上研究,28人(90.3%)曾收到RAIS的通知,26人(92.9%)在研究批准到期前4周向伦理委员会和监管机构提交了研究批准续期申请。该研究还考察了参与者对监管要求的总体理解,所有人都知道伦理审查委员会(RECs)和新药申请(NDA)授予的批准有效期为1年,35人(97.2%)知道乌干达国家科学技术委员会(UNCST)在研究期间授予批准。通过关键信息访谈得出了三个突出主题:研究人员对RAIS的体验、益处和缺点。
有研究经验并结合一个新颖的自动化系统,为更好地理解研究监管要求提供了一个平台,从而有助于遵守国家准则。
我们的案例研究表明,在资源匮乏地区为研究人员和研究机构提供一个跟踪研究批准到期日期的自动化系统,可以促进对国家伦理准则的遵守。